Genmab AS Long-term Investment Intensity
Genmab AS long-term investment intensity. Genmab AS (GMAB) has a Long-term Investment Intensity of 0.3% as of December 2025. Long-term investments of $37.00 Million represent 0.3% of total assets of $12.84 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Genmab AS balance sheet liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Genmab AS (2019–2025)
Long-term investment intensity of Genmab AS from 2019 to 2025. This chart shows how Genmab AS's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the intensity stands at 0.3%, reflecting long-term investments of $37.00 Million against total assets of $12.84 Billion USD.
Genmab AS Long-term Investment Intensity by Year (2019–2025)
Genmab AS long-term investment intensity by year from 2019 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Genmab AS from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see GMAB total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.3% | $37.00 Million | $12.84 Billion | ▼ -0.2 pp |
| 2024 | 0.5% | $228.00 Million | $45.81 Billion | ▲ +0.1 pp |
| 2023 | 0.4% | $134.00 Million | $35.29 Billion | ▼ -0.1 pp |
| 2022 | 0.4% | $133.00 Million | $30.12 Billion | ▼ -1.1 pp |
| 2021 | 1.5% | $371.00 Million | $24.63 Billion | ▼ -3.6 pp |
| 2020 | 5.1% | $1.08 Billion | $21.14 Billion | ▲ +4.1 pp |
| 2019 | 1.0% | $149.00 Million | $15.14 Billion | — |